Parker Research Institute

The Parker Institute for Cancer Immunotherapy (PICI) is a leading non-profit research organization founded in 2016 by entrepreneur Sean Parker to accelerate the development of transformative immune therapies for cancer. Operating as a collaborative network, PICI unites the world's top immunologists and cancer centers—including Memorial Sloan Kettering, Stanford Medicine, and the University of Pennsylvania—under a unified intellectual property and data-sharing framework. The institute provides significant funding and centralized resources to bridge the gap between academic discovery and commercial drug development. PICI's portfolio includes a diverse range of clinical trials, notably the PRINCE and REVOLUTION trials in pancreatic cancer, focusing on novel combinations of checkpoint inhibitors and cell therapies. By fostering deep collaborations between academia and the biopharmaceutical industry, PICI aims to rapidly translate scientific breakthroughs into standard-of-care treatments.